Hypnagogic and hypnopompic hallucinations during amitriptyline treatment.
Acta Psychiatrica Scandinavica October 1, 1980 DOI: 10.1111/j.1600-0447.1980.tb00622.x (opens in new tab) via PubMed
Summary
AI-generated from the abstractFour patients taking amitriptyline experienced brief visual hallucinations when falling asleep or waking up. The hallucinations were vivid, projected into the room, and briefly felt real, but patients quickly recognized them as unreal, likely because they remained critically aware and coherent. The report suggests a possible link between amitriptyline's brain effects, altered sleep patterns, and clinical improvement. Patients should be told these hallucinations are benign to prevent them from stopping treatment prematurely.
Study at a glance
| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 4 |
| Population | Patients treated with amitriptyline |
| Intervention | Amitriptyline |
| Key finding | Amitriptyline treatment can cause hypnagogic or hypnopompic visual hallucinations that are benign and self-limited. |
Abstract
Four cases of hypnagogic or hypnopompic visual hallucinations in patients during amitriptyline treatment are reported. The hallucinations were clearly delineated, projected to the outer objective space and were for a short time experienced as real. The patients rapidly realized the unreality of the "sights", probably because they regained the full criticism and coherent thinking of an unpsychotic awake individual. There may be a relation between the effects of amitriptyline in brain, the changed pattern of sleep and the clinical recovery. Patients should be informed about the benign character of this type of hallucinatory phenomena so that treatment is not terminated at an undue time.